Researchers Say CAEL-101 is an Effective Amyloid Light Chain Amyloidosis Treatment

Conference|ASH Annual Meeting and Exposition - American Society of Hematology Annual Meeting and Exposition

Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about his new research surrounding CAEL-101, a treatment for patients living with amyloid light chain amyloidosis.

Pharmacy Times^® interviewed Jason Valent, MD, of the Cleveland Clinic about his new research surrounding CAEL-101, a treatment for patients living with amyloid light chain amyloidosis, which was presented at the 62^nd American Society of Hematology Annual Meeting & Exposition.

The full conversation can be found in the video above.